FIELD: lymphology; cardiovascular surgery.
SUBSTANCE: invention can be used to determine the likelihood of developing a complicated course of the disease in patients with secondary lymphedema of the lower extremities. Determination is carried out in the peripheral venous blood of patients with secondary lymphedema of the lower extremities using the competitive enzyme immunoassay test for catalase and superoxide dismutase. The subsequent calculation of the probability of developing a complicated course of lymphedema is carried out using the formula Р = 1/(1 + е-Z), where P is the probability of developing a complicated course of secondary lymphedema of the lower extremities within 5 years, e is the base of the natural logarithm (Euler’s number), and z is the indicator calculated as follows: Z = -119.8 + 155.64 * X1 + 36.67 * X2, X1 is the catalase level, X2 is the superoxide dismutase level.
EFFECT: method provides the ability to predict the complicated course of secondary lymphedema of the lower extremities by determining the level of catalase and superoxide dismutase in the blood using a competitive enzyme-linked immunosorbent test.
1 cl, 2 tbl, 5 ex
Title |
Year |
Author |
Number |
METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN PATIENTS WITH SECONDARY LYMPHEDEMA OF LOWER EXTREMITIES |
2019 |
- Kalinin Roman Evgenevich
- Suchkov Igor Aleksandrovich
- Maksaev Denis Alekseevich
|
RU2720815C1 |
METHOD FOR PREDICTING PROGRESSIVE RESTENOTIC PROCESS DEVELOPMENT AFTER SURGICAL INTERVENTION ON GREATER ARTERIES IN LOWER EXTREMITY OBLITERATING ATHEROSCLEROSIS PATIENTS |
2006 |
- Kalinin Roman Evgen'Evich
|
RU2319452C1 |
DIAGNOSTIC TECHNIQUE FOR METABOILIC DISORDERS IN BODY IN OXIDATIVE STRESS ENVIRONMENT |
2010 |
- Basov Aleksandr Aleksandrovich
- Pavljuchenko Ivan Ivanovich
- Bykov Il'Ja Mikhajlovich
- Fedosov Sergej Rostislavovich
- Gubareva Elena Aleksandrovna
|
RU2436101C1 |
GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING THE TARGET GENE SELECTED FROM THE SOD1, SOD2, SOD3, CAT GENE GROUP TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD1 STRAIN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CAT, CARRYING A GENE-THERAPEUTIC DNA VECTOR, A METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR |
2018 |
|
RU2731515C2 |
METHOD FOR PREDICTING FATAL OUTCOMES IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF ARTERIES OF LOWER EXTREMITIES AFTER ENDOVASCULAR RECONSTRUCTIONS |
2021 |
- Kalinin Roman Evgenevich
- Suchkov Igor Aleksandrovich
- Mzhavanadze Nina Dzhansugovna
- Povarov Vladislav Olegovich
|
RU2752823C1 |
METHOD FOR EARLIER DIAGNOSTICS OF BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES |
2000 |
- Brekhova I.S.
- Volkov N.A.
- Titova N.M.
- Polstjanaja G.N.
|
RU2190221C2 |
METHOD OF EARLY PREDICTION OF RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS |
2022 |
- Kostyushok Nadezhda Yanovna
- Ivanova Lyudmila Aleksandrovna
- Pavlyuchenko Ivan Ivanovich
|
RU2812643C2 |
METHOD FOR EARLY PREDICTION OF THE RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS |
2022 |
- Kostyushok Nadezhda Yanovna
- Ivanova Lyudmila Aleksandrovna
- Pavlyuchenko Ivan Ivanovich
|
RU2793531C1 |
NON-INVASIVE METHOD FOR ASSESSING INTENSITY OF APOPTOTIC PROCESSES IN TYPE 1 DIABETES MELLITUS PATIENTS |
2019 |
- Cheprasova Anna Aleksandrovna
- Pashkov Aleksandr Nikolaevich
- Popov Sergej Sergeevich
- Popova Tatyana Nikolaevna
- Shulgin Konstantin Konstantinovich
- Verevkin Aleksej Nikolaevich
|
RU2708240C1 |
METHOD FOR LOCAL TREATMENT AND PREVENTION OF GINGIVITIS IN FEMALES WITH GESTOSIS COMPLICATED PREGNANCY, USING CHEWY PHYTOSUBSTRATUS |
2019 |
- Chujkin Sergej Vasilevich
- Egorova Elena Gertrudovna
- Maganova Zarema Sharifyanovna
- Kudashkina Natalya Vladimirovna
|
RU2687977C1 |